Skip to content
10-Q

Quarterly Report

AVADEL PHARMACEUTICALS PLC

0001012477-25-000024

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 97.1M sh
Shares Diluted Q2 2025 · Jun 30, 2025 99.09M sh
Shares Diluted Q2 2025 · Jun 30, 2025 98.89M sh
Shares Diluted Q2 2025 · Jun 30, 2024 96.15M sh
Shares Diluted Q2 2025 · Jun 30, 2024 93.92M sh
Capex Q2 2025 · Jun 30, 2025 $181K
Capex Q2 2025 · Jun 30, 2024 $0
Operating Cash Flow Q2 2025 · Jun 30, 2025 $4.47M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$47.89M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $63.4M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $51.37M
Stockholders Equity Q2 2025 · Jun 30, 2025 $90.71M
Stockholders Equity Q2 2025 · Mar 31, 2025 $74.07M
Stockholders Equity Q2 2025 · Dec 31, 2024 $73.85M
Stockholders Equity Q2 2025 · Jun 30, 2024 $70.29M
Stockholders Equity Q2 2025 · Mar 31, 2024 $78.38M
Stockholders Equity Q2 2025 · Dec 31, 2023 $87.74M
Current Liabilities Q2 2025 · Jun 30, 2025 $57.07M
Current Liabilities Q2 2025 · Dec 31, 2024 $48.83M
Total Liabilities Q2 2025 · Jun 30, 2025 $96.45M
Total Liabilities Q2 2025 · Dec 31, 2024 $90.39M
Current Assets Q2 2025 · Jun 30, 2025 $159.11M
Current Assets Q2 2025 · Dec 31, 2024 $134.21M
Total Assets Q2 2025 · Jun 30, 2025 $187.16M
Total Assets Q2 2025 · Dec 31, 2024 $164.24M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.10
Eps Diluted Q2 2025 · Jun 30, 2025 $0.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.14
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.44
Eps Basic Q2 2025 · Jun 30, 2025 $0.10
Eps Basic Q2 2025 · Jun 30, 2025 $0.05
Eps Basic Q2 2025 · Jun 30, 2024 −$0.14
Eps Basic Q2 2025 · Jun 30, 2024 −$0.44
Sga Expense Q2 2025 · Jun 30, 2025 $48.62M
Sga Expense Q2 2025 · Jun 30, 2025 $94.21M
Sga Expense Q2 2025 · Jun 30, 2024 $47.41M
Sga Expense Q2 2025 · Jun 30, 2024 $96.03M
Rd Expense Q2 2025 · Jun 30, 2025 $4.26M
Rd Expense Q2 2025 · Jun 30, 2025 $8.61M
Rd Expense Q2 2025 · Jun 30, 2024 $4.05M
Rd Expense Q2 2025 · Jun 30, 2024 $7.12M
Net Income Q2 2025 · Jun 30, 2025 $9.67M
Net Income Q2 2025 · Jun 30, 2025 $4.75M
Net Income Q2 2025 · Mar 31, 2025 −$4.92M
Net Income Q2 2025 · Jun 30, 2024 −$13.82M
Net Income Q2 2025 · Jun 30, 2024 −$41.16M
Net Income Q2 2025 · Mar 31, 2024 −$27.34M
Operating Income Q2 2025 · Jun 30, 2025 $8.88M
Operating Income Q2 2025 · Jun 30, 2025 $5.88M
Operating Income Q2 2025 · Jun 30, 2024 −$12.74M
Operating Income Q2 2025 · Jun 30, 2024 −$38.78M
Gross Profit Q2 2025 · Jun 30, 2025 $61.76M
Gross Profit Q2 2025 · Jun 30, 2025 $108.7M
Gross Profit Q2 2025 · Jun 30, 2024 $38.72M
Gross Profit Q2 2025 · Jun 30, 2024 $64.37M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $6.37M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $11.94M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $2.79M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $4.31M
Revenue Q2 2025 · Jun 30, 2025 $68.13M
Revenue Q2 2025 · Jun 30, 2025 $120.64M
Revenue Q2 2025 · Jun 30, 2024 $41.5M
Revenue Q2 2025 · Jun 30, 2024 $68.68M